Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Abstract Parkinson’s disease (PD) is now considered to be a multisystemic disorder consequent on multineuropeptide dysfunction including dopaminergic, serotonergic, cholinergic, and noradrenergic systems. This multipeptide dysfunction leads to expression of a range of non-motor symptoms now known to...
Main Authors: | MA Qamar, A Sauerbier, M Politis, H Carr, P Loehrer, K Ray Chaudhuri |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-01-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-016-0006-9 |
Similar Items
-
Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naïve Parkinson's patients.
by: Sotirios Polychronis, et al.
Published: (2019-01-01) -
DOPAMINERGIC AND NON-DOPAMINERGIC MECHANISMS OF NON-MOTOR SYMPTOMS OF PARKINSON DISEASE
by: Titus Mihai Vasile, et al.
Published: (2012-12-01) -
Dural Arteriovenous Fistula-Associated Reversible Parkinsonism with Presynaptic Dopaminergic Loss
by: Hang Rai Kim, et al.
Published: (2015-09-01) -
Effect of hypothalamic hormones on presynaptic dopaminergic mechanisms
by: Shapiro, L. M.
Published: (1978) -
Differential Loss of Presynaptic Dopaminergic Markers in Parkinsonian Monkeys
by: Diane T. Stephenson Ph.D., et al.
Published: (2007-03-01)